AV网站国产不卡|a阿V天堂亚洲阿∨天堂在线|a在线视频播放免费视|yy717午夜福利

<sup id="zd4np"></sup>

array(25) {
  ["id"]=>
  string(5) "79797"
  ["name"]=>
  string(9) "黃培鈺"
  ["avatar"]=>
  string(72) "https://img.39yst.com/uploads/19763/6d688978f87471397bc2911c1b9c8260.jpg"
  ["status"]=>
  string(1) "0"
  ["rank_type"]=>
  string(1) "1"
  ["duodian_main_id"]=>
  string(1) "0"
  ["miaopai"]=>
  string(0) ""
  ["graphic_consult"]=>
  string(1) "0"
  ["position"]=>
  string(12) "主任醫(yī)師"
  ["introduction"]=>
  string(5117) "一、基本情況：
職稱：主任醫(yī)師、博士生導師
專長：鼻咽癌的放療、化療以及免疫、分子靶向的綜合治療。

二、主要學歷：
1995.9 -2002.7? 中山醫(yī)科大學臨床醫(yī)學七年制本碩連讀。
2005.9 -2009.7??中山大學腫瘤防治中心博士研究生。
?
三、工作經(jīng)歷：
從事鼻咽癌的臨床診治工作20余年。診治鼻咽癌患者近萬例。對鼻咽癌綜合治療，特別是放療、化療及免疫、分子靶向治療有豐富的臨床經(jīng)驗。2016年于美國排名第一的MD Anderson 癌癥中心作為訪問副教授學習一年。2018年底起任中山大學腫瘤防治中心鼻咽癌科主任醫(yī)師。
具有豐富的臨床教學經(jīng)驗，被評為2013年中山大學優(yōu)秀臨床帶教老師。
開展多項鼻咽癌治療的臨床研究，發(fā)表在《柳葉刀》、《美國醫(yī)學會雜志·腫瘤學》等國際權(quán)威期刊，成果被美國NCCN指南、中國CSCO指南等國內(nèi)外權(quán)威指南采納。榮獲2019年、2023年中國抗癌協(xié)會科技獎一等獎；2019年廣東醫(yī)學科技獎一等獎。
?
四、學術任職：
中國醫(yī)促會鼻咽癌防治分會委員
廣東省抗癌協(xié)會鼻咽癌專業(yè)委員會委員
廣東省臨床醫(yī)學精準醫(yī)療專業(yè)委員會委員
?廣東省醫(yī)院協(xié)會腫瘤防治管理分會委員
?
五、主要研究方向：
鼻咽癌的放療、化療以及免疫、分子靶向的綜合治療研究。
?
六、科研及基金：
1. 主持國家自然科學基金面上項目1項（項目編號，81874134，54萬經(jīng)費）
2. 主持中山大學臨床5010常規(guī)項目1項（項目編號，2018015，160萬經(jīng)費）
3. 主持廣東省醫(yī)學科研基金2項
4. 主持中山大學青年教師培育項目1項
5. 主持中山大學臨床5010培育項目1項
?
七、第一/通訊作者（含共同）文章節(jié)選：
1.You R, Liu YP, Xie YL,...,Huang PY*（共同通訊）, Chen MY*. Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.?Lancet.?2023 Mar 18;401(10380):917-927.?(IF 168.9?)
2.Chen SY, Duan XT, Li HF, Peng L, Wang ZQ, Xu GQ, Hua YJ, Zou X, You R, Ouyang YF, Liu YP, Gu CM, Yang Q, Jiang R, Zhang MX, Lin M, Xie YL, Lin C, Ding X, Xie RQ, Duan CY, Zhang WJ, Huang PY*（共同通訊），?Chen MY*.?Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic?nasopharyngeal?carcinoma: A phase II trial.Cell Rep Med?2023 Nov 21;4(11):101279.?(IF 14.3??)
3.You R, Liu YP, Huang PY?(co-first author), et al. Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial, JAMA Oncol. 2020 Sep 1;6(9):1345-1352. ?(IF 28.4?)
4. Huang PY, Zeng Q, Cao KJ, Guo X, Guo L, Mo HY, Wu PH, Qian CN, Mai HQ, Hong MH. Ten-year outcomes of a randomised trial for locoregionally advanced?nasopharyngeal?carcinoma: A single-institution experience from an endemic area.Eur J Cancer. 2015 Sep;51(13):1760-70. (IF ?8.4??)
5. Huang PY, Wang CT, Cao KJ, Guo X, Guo L, Mo HY, Wen BX, Wu YS, Mai HQ, Hong MH *. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial. Eur J Cancer. 2013 May;49(8):1923-31. ?(IF 8.4?)
6. Peng PJ, Lv BJ, Wang ZH, Liao H, Liu YM, Lin Z, Con YY,?Huang PY(Corresponding author). Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic?nasopharyngeal?carcinoma patients after failure of platinum-containing regimens.
Ther Adv Med Oncol. 2017 Feb;9（2）:68-74. ?(IF 4.9)
7. Wu,X, Huang PY (Co-first author), Peng, PJ，Han F, Zhao C, Zhang L*. Long term follow up of a PhaseIII Study Comparing Radiotherapy with or without Weekly Oxaliplatin for Locoregionally Advanced Nasopharyngeal Carcinoma. Ann Oncol. 2013 Aug;24(8):2131-6. (IF ?50.5? )
8. Xue C, Huang Y, Huang PY (Co-first author), Yu QT, Pan JJ, Liu LZ, Song XQ, Lin SJ, Wu JX, Zhang JW, Zhao HY, Xu F, Liu JL, Hu ZH, Zhao LP, Zhao YY, Wu X, Zhang J, Ma YX, Zhang L*. ?Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma. Ann Oncol. 2013 Apr;24(4):1055-61. (IF ?50.5? )
9. Zhang L, MacIsaac KD, Zhou T, Huang PY(Co-first author), Xin C, Dobson JR, Yu K, Chiang DY, Fan Y, Pelletier M, Wang Y, Jaeger S, Krishnamurthy Radhakrishnan V, JeBailey L, Skewes-Cox P, Zhang J, Fang W, Huang Y, Zhao H, Zhao Y, Li E, Peng B, Huang A, Dranoff G, Hammerman PS, Engelman J, Bitter H, Zeng YX, Yao Y. Genomic Analysis of?Nasopharyngeal?Carcinoma Reveals TME-Based Subtypes.?Mol Cancer Res. 2017 Dec;15（12）:1722-1732.?(IF?5.2)
?
八、編寫書籍：
鼻咽癌診療規(guī)范手冊，人民衛(wèi)生出版社?編委
鼻咽癌微創(chuàng)外科學?廣東科技出版社 ?編委
?
?
更新時間：2024年1月27日"
  ["adept"]=>
  string(72) "鼻咽癌的放療、化療以及免疫、分子靶向的綜合治療。"
  ["duodian_doctor_id"]=>
  string(6) "115152"
  ["source_from"]=>
  string(12) "醫(yī)院官網(wǎng)"
  ["is_jingxuan"]=>
  string(1) "0"
  ["title_num"]=>
  string(0) ""
  ["created"]=>
  string(10) "1754967844"
  ["doctor_title"]=>
  string(12) "主任醫(yī)師"
  ["is_seniority"]=>
  int(1)
  ["province_id"]=>
  int(0)
  ["city_id"]=>
  int(0)
  ["hospital_sort"]=>
  string(2) "32"
  ["hospital"]=>
  array(1) {
    [0]=>
    array(31) {
      ["id"]=>
      string(5) "19763"
      ["name"]=>
      string(30) "中山大學腫瘤防治中心"
      ["grade_id"]=>
      string(1) "2"
      ["grade"]=>
      string(0) ""
      ["type"]=>
      string(1) "1"
      ["duodian_hospital_id"]=>
      string(3) "814"
      ["address"]=>
      string(27) "廣州市東風東路651號"
      ["is_gongli"]=>
      string(1) "1"
      ["logo"]=>
      string(72) "http://pic.39yst.com/group2/M00/8B/F7/Co2PPWKfAdKACBy1AABiOqd-PC074.jpeg"
      ["is_pay"]=>
      string(1) "0"
      ["pic"]=>
      string(72) "http://pic.39yst.com/group2/M00/99/67/Co2PPWZ-H3qABl2PAAK_8SuU6HY43.jpeg"
      ["is_top100"]=>
      string(1) "1"
      ["parent_areaid"]=>
      string(2) "19"
      ["areaid"]=>
      string(4) "1601"
      ["top100_sort"]=>
      string(2) "32"
      ["guide"]=>
      string(0) ""
      ["tel"]=>
      string(38) "020-87673713，020-87765368           "
      ["is_seniority"]=>
      string(1) "1"
      ["hospital_title"]=>
      string(6) "三甲"
      ["hospital_grade_id"]=>
      string(1) "2"
      ["hospital_type"]=>
      string(12) "綜合醫(yī)院"
      ["hospital_type_id"]=>
      string(1) "1"
      ["hospital"]=>
      string(30) "中山大學腫瘤防治中心"
      ["department_id"]=>
      string(2) "34"
      ["duodian_department_id"]=>
      string(5) "11865"
      ["duodian_department_pid"]=>
      string(5) "11850"
      ["department_name"]=>
      string(9) "耳鼻喉"
      ["standard_department_id"]=>
      string(2) "34"
      ["parent_standard_department_id"]=>
      string(3) "103"
      ["hospital_department"]=>
      string(9) "鼻咽科"
      ["duty"]=>
      array(0) {
      }
    }
  }
  ["version"]=>
  int(40)
  ["isHaveSource"]=>
  int(0)
  ["duty"]=>
  string(0) ""
}